Cognivive Inc. Announces World’s First Prescription Interactive Rehabilitation Device Under New FDA Regulation
Cognivive Inc. is digital medicine company that develops neurorehabilitation treatments, delivered in the form of highly motivating virtual reality games that patients use at home to speed and improve recovery from stroke, monitored and guided by treating clinicians. Theirs is the first prescription interactive rehabilitation device under new FDA regulation. Cognivive's remote-use treatments are the perfect solution to the challenges posed to neurorehabilitation care by COVID-19. - August 15, 2020
Press Releases 1 - 1 of 1